...in the news

Displaying 61 - 70 of 126 (10 per page)

Score	HS	BSN	CLB	EQT	IPO	M&A	IP	Date
								May 14, 2015
Arcadia Biosciences, Inc. Announces Pricing of Initial Public Offering
								Apr 6, 2015
Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
								Oct 31, 2014
TPG-backed biotech Virobay withdraws $50 million IPO
								Dec 20, 2013
CombiMatrix Closes $12 Million Underwritten Public Offering
								Nov 14, 2014
FibroGen's $146M IPO haul vaults to top of Bay Area biotech offerings
								Aug 5, 2014
Avalanche Biotechnologies Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
								Mar 24, 2014
New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties
								Jan 1, 2012
Cancer Genetics Inc., a Rutherford, N.J.-based cancer diagnostics company, has postponed its $50 million IPO
								Jun 30, 2014
Gene therapy company Avalanche Bio seeks $86 million IPO
								Jan 31, 2007
Tranzeo Wireless Completes Sensoria Corporation Asset Acquisition: Transaction adds wireless mesh networking equipment and engineering expertise to Tranzeo's portfolio of wireless point-to-point and -multipoint solutions.